Ginkgo Bioworks Holdings Inc (DNA) Q3 2024 Earnings Call Highlights: Strategic Restructuring ... [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
R&D Expense: Decreased from $108 million in Q3 2023 to $74 million in Q3 2024. G&A Expense: Decreased from $49 million in Q3 2023 to $42 million in Q3 2024. Adjusted EBITDA: Negative $20 million in Q3 2024, improved from negative $84 million in Q3 2023. Cash Burn: Impacted by $23 million due to nonrecurring items in Q3 2024. Revenue Guidance: Updated to $215 million to $235 million for the full year 2024. Cell Engineering Services Revenue Guidance: $165 million to $185 million for the full year 2024. Biosecurity Revenue Guidance: At least $50 million for the full year 2024. Warning! GuruFocus has detected 5 Warning Signs with DNA. Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Ginkgo Bioworks Holdings Inc ( NYSE:DNA ) reported a 17% increase in active programs year over year, indicating growth in their cell engineering platform. The company successfully reduced R&D and G&A expen
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Ginkgo Bioworks eligible for $9.4M in partnership for bioelectronic devices [Seeking Alpha]Seeking Alpha
- Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT ProgramPR Newswire
- Upstream Bio Appoints Allison Ambrose as General Counsel [Yahoo! Finance]Yahoo! Finance
- Industrial Biomanufacturing Market Report 2025-2035, with Profiles of 1,100+ Companies Active in the Industrial Biomanufacturing Space [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 11/12/24 - Beat
DNA
Sec Filings
- 12/26/24 - Form 144
- 12/26/24 - Form 144
- 12/23/24 - Form 144
- DNA's page on the SEC website